Science and Research

Modulation of Pancreatic Neuroendocrine Neoplastic Cell Fate by Autophagy-Mediated Death

INTRODUCTION: Autophagic cell death in cancer cells can be mediated by inhibition of deacetylases. Although extensive studies have focused on the autophagic process in cancer, little is known about the role of autophagy in degrading cytosolic and nuclear components of pancreatic neuroendocrine neoplastic (pNEN) cells leading to cell death, thus improving the therapy of patients affected by pNEN. METHODS: 2D and 3D human pNEN and pancreatic stellate cells were treated with panobinostat and bafilomycin. Autophagy markers were detected by RT-qPCR, immunofluorescence, and Western blot. Autophagosomes were detected by electron microscopy and their maturation by real-time fluorescence of LC3B stable transfected cells. ChIP was performed at the cAMP responsive element. Immunofluorescence was performed in murine pancreatic tissue. RESULTS: We observed that pan-deacetylase inhibitor panobinostat treatment causes autophagic cell death in pNEN cells. We also found that although AMPK-α phosphorylation is counterbalanced by phosphorylated AKT, it is not capable to inhibiting autophagic cell death. However, the binding activity of the cAMP responsive element is prompted by panobinostat. Although autophagy inhibition prevented autophagosome synthesis, maturation, and cell death, panobinostat treatment induced the accumulation of mature autophagosomes in the cytosol and the nucleus, leading to disruption of the organelles, cellular digestion, and decay. Observation of autophagosome membrane proteins Beclin1 and LC3B aggregation in murine pancreatic islets indicates that autophagy restoration may also lead to autophagosome aggregation in murine insulinoma cells. A basal low expression of autophagy markers was detectable in patients affected by pNEN, and, interestingly, the expression of these markers was significantly lower in metastatic pNEN. DISCUSSION/CONCLUSION: Our study highlights that the autophagy functional restoration and prolongation of this catabolic process, mediated by inhibition of deacetylase, is responsible for the reduction of pNEN cells. Prompting of autophagy cell death could be a promising strategy for the therapy of pNEN.

  • Matrood, S.
  • de Prisco, N.
  • Wissniowski, T. T.
  • Wiese, D.
  • Jabari, S.
  • Griesmann, H.
  • Wanzel, M.
  • Stiewe, T.
  • Neureiter, D.
  • Klieser, E.
  • Mintziras, I.
  • Buchholz, M.
  • Bartsch, D. K.
  • Gennarino, V. A.
  • Di Fazio, P.

Keywords

  • Autophagic Cell Death/*drug effects
  • Cell Line, Tumor
  • Enzyme Inhibitors/*pharmacology
  • Humans
  • Neuroendocrine Tumors/*drug therapy
  • Pancreatic Neoplasms/*drug therapy
  • Panobinostat/pharmacology
  • *Activated protein kinase
  • *Autophagy
  • *Cell death
  • *Insulinoma
  • *Pancreatic neuroendocrine cancer
  • *Spheroids
Publication details
DOI: 10.1159/000512567
Journal: Neuroendocrinology
Pages: 965-985 
Number: 10
Work Type: Original
Location: UGMLC
Disease Area: LC
Partner / Member: UMR
Access-Number: 33108790

DZL Engagements

chevron-down